LifeMD stock soars 16% on earnings beat, strong guidance

Published 10/03/2025, 21:28
LifeMD stock soars 16% on earnings beat, strong guidance

NEW YORK - LifeMD , Inc. (NASDAQ:LFMD) shares surged 16% after the virtual primary care provider reported fourth-quarter earnings that exceeded analyst expectations and provided robust guidance for 2025.

The company reported adjusted earnings per share of $0.21, beating the analyst estimate of -$0.05 by $0.26. Revenue for the quarter came in at $64.3 million, up 43% YoY and surpassing the consensus estimate of $57.66 million.

LifeMD’s telehealth revenue grew 60% YoY to $49.9 million, while its telehealth active subscribers increased 27% to approximately 275,000. The company’s adjusted EBITDA rose 78% to $9.0 million.

For the first quarter of 2025, LifeMD expects total revenue between $61 million and $63 million, above the consensus of $60 million. For the full year 2025, the company forecasts revenue of $265 million to $275 million, surpassing analyst expectations of $258 million.

"LifeMD had a great fourth quarter. We not only achieved record quarterly revenue and adjusted EBITDA but continued to accelerate growth across our core telehealth brands," said Justin Schreiber, Chairman and CEO of LifeMD.

The company highlighted the growth of its weight management program and plans to launch a Medicare offering on April 1, which could be a significant growth driver. LifeMD ended 2024 with over $35 million in cash and generated positive full-year net cash flow.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.